Janus Henderson Group PLC Care Dx, Inc. Transaction History
Janus Henderson Group PLC
- $194 Billion
- Q2 2025
A detailed history of Janus Henderson Group PLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 21,900 shares of CDNA stock, worth $333,318. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,900
Previous 21,900
-0.0%
Holding current value
$333,318
Previous $388,000
10.05%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CDNA
# of Institutions
211Shares Held
56MCall Options Held
85KPut Options Held
33.1K-
Black Rock Inc. New York, NY5.29MShares$80.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.91MShares$74.7 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.54MShares$38.7 Million0.01% of portfolio
-
Bamco Inc New York, NY2.44MShares$37.1 Million0.14% of portfolio
-
State Street Corp Boston, MA2.18MShares$33.2 Million0.0% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $814M
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...